Re: Brown et al.: MERLIN: Two-year results of brolucizumab in participants with neovascular age-related macular degeneration and persistent retinal fluid. (Ophthalmology. 2025;132:131–140)

IF 9.5 1区医学 Q1 OPHTHALMOLOGY

Ophthalmology Pub Date : 2025-07-26 DOI:10.1016/j.ophtha.2025.06.008

Xiaoqian Liu MD , Guangsen Liu MD , Qiang Zhang MD

引用次数: 0

查看原文本刊更多论文

Re: Brown等人：MERLIN: brolucizumab在新生血管性年龄相关性黄斑变性和持续性视网膜积液患者中的两年结果。(眼科学。2025;132:131 - 140)。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Ophthalmology 医学-眼科学

CiteScore

22.30

自引率

3.60%

发文量

412

审稿时长

18 days

期刊介绍： The journal Ophthalmology, from the American Academy of Ophthalmology, contributes to society by publishing research in clinical and basic science related to vision.It upholds excellence through unbiased peer-review, fostering innovation, promoting discovery, and encouraging lifelong learning.